Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis

doi:10.4254/wjh.v14.i4.744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8165)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

322

WORD

HTML

4259

Figures (1-1)

354

Tables (1-4)

322

Sum=5325

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

263

Download

611

Sum=874

Publishing Process of This Article

Item

Count

Browse

492

Download

1474

Sum=1966

Apr 27, 2022 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Hepatol. Apr 27, 2022; 14(4): 744-753
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.744

Table 3 Table summarizing the P value of the studied characteristics

Characteristic	P value
Age	0.0036
Gender	0.23
ALT	0.71
AST	0.07
Albumin	0.44
Cholesterol	0.22
GGT	0.22
LDL	0.07
HDL	0.68
ALP	0.033
Triglycerides	0.57
Bilirubin	0.0001
Glucose	0.0063
Platelet count	0.0001
PT INR	0.0011
PTT	0.0054

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; PPT: Partial thromboplastin time.

Citation: Al Danaf L, Hussein Kamareddine M, Fayad E, Hussain A, Farhat S. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis. World J Hepatol 2022; 14(4): 744-753
URL: https://www.wjgnet.com/1948-5182/full/v14/i4/744.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i4.744